328 related articles for article (PubMed ID: 16359211)
21. Endoscopic treatment of primary grade V vesicoureteral reflux using hyaluronic acid copolymer (DX/HA).
Hunziker M; Mohanan N; D'Asta F; Puri P
Pediatr Surg Int; 2010 Oct; 26(10):977-9. PubMed ID: 20625750
[TBL] [Abstract][Full Text] [Related]
22. A comparison between dextranomer/ hyaluronic acid and polyacrylate polyalcohol copolymer as bulking agents for treating primary vesicoureteral reflux.
Alizadeh F; Omidi I; Haghdani S; Hatef Khorrami M; Izadpanahi MH; Mohammadi Sichani M
Urol J; 2019 May; 16(2):174-179. PubMed ID: 30178456
[TBL] [Abstract][Full Text] [Related]
23. Subureteral dextranomer/hyaluronic acid injection as first line treatment in the management of high grade vesicoureteral reflux.
Puri P; Pirker M; Mohanan N; Dawrant M; Dass L; Colhoun E
J Urol; 2006 Oct; 176(4 Pt 2):1856-9; discussion 1859-60. PubMed ID: 16945672
[TBL] [Abstract][Full Text] [Related]
24. The role of intraoperative cystography following the injection of dextranomer/hyaluronic acid copolymer.
Palmer LS
J Urol; 2008 Mar; 179(3):1118-20; discussion 1121. PubMed ID: 18206944
[TBL] [Abstract][Full Text] [Related]
25. Are there predictive factors for the outcome of endoscopic treatment of grade III-V vesicoureteral reflux with dextranomer/hyaluronic acid in children?
Altug U; Cakan M; Yilmaz S; Yalçinkaya F
Pediatr Surg Int; 2007 Jun; 23(6):585-9. PubMed ID: 17356857
[TBL] [Abstract][Full Text] [Related]
26. Endoscopic Deflux injection for pediatric transplant reflux: a feasible alternative to open ureteral reimplant.
Williams MA; Giel DW; Colleen Hastings M
J Pediatr Urol; 2008 Oct; 4(5):341-4. PubMed ID: 18790416
[TBL] [Abstract][Full Text] [Related]
27. Comparison of results of endoscopic correction of vesicoureteral reflux in children using two bulking substances: Dextranomer/hyaluronic acid copolymer (Deflux) versus polyacrylate-polyalcohol copolymer (Vantris).
Warchol S; Krzemien G; Szmigielska A; Bombinski P; Brzewski M; Dudek-Warchol T
J Pediatr Urol; 2016 Aug; 12(4):256.e1-4. PubMed ID: 27593921
[TBL] [Abstract][Full Text] [Related]
28. Dextranomer/hyaluronic acid copolymer implantation for vesico-ureteral reflux: a randomized comparison with antibiotic prophylaxis.
Capozza N; Caione P
J Pediatr; 2002 Feb; 140(2):230-4. PubMed ID: 11865276
[TBL] [Abstract][Full Text] [Related]
29. Is routine voiding cystourethrogram necessary following double hit for primary vesicoureteral reflux?
Arlen AM; Scherz HC; Filimon E; Leong T; Kirsch AJ
J Pediatr Urol; 2015 Feb; 11(1):40.e1-5. PubMed ID: 25725613
[TBL] [Abstract][Full Text] [Related]
30. Endoscopic treatment with dextranomer/hyaluronic acid for complex cases of vesicoureteral reflux.
Perez-Brayfield M; Kirsch AJ; Hensle TW; Koyle MA; Furness P; Scherz HC
J Urol; 2004 Oct; 172(4 Pt 2):1614-6. PubMed ID: 15371773
[TBL] [Abstract][Full Text] [Related]
31. [Long-term results after endoscopic subureteral injection for VUR using dextranomer/hyaluronic acid copolymer : a five years experience].
Seibold J; Werther M; Sievert KD; Stenzl A
Urologe A; 2010 Apr; 49(4):536-9. PubMed ID: 20063087
[TBL] [Abstract][Full Text] [Related]
32. Febrile urinary tract infections after ureteroneocystostomy and subureteral injection of dextranomer/hyaluronic acid for vesicoureteral reflux--do choice of procedure and success matter?
Dwyer ME; Husmann DA; Rathbun SR; Weight CJ; Kramer SA
J Urol; 2013 Jan; 189(1):275-82. PubMed ID: 23174239
[TBL] [Abstract][Full Text] [Related]
33. The cost-effectiveness of endoscopic injection of dextranomer/hyaluronic acid copolymer for vesicoureteral reflux.
Kobelt G; Canning DA; Hensle TW; Läckgren G
J Urol; 2003 Apr; 169(4):1480-4; discdussion 1484-5. PubMed ID: 12629396
[TBL] [Abstract][Full Text] [Related]
34. Endoscopic treatment of vesicoureteral reflux in an adult population: Can we teach our adult urology colleagues?
Natsheh A; Shenfeld OZ; Farkas A; Chertin B
J Pediatr Urol; 2010 Dec; 6(6):600-4. PubMed ID: 20189882
[TBL] [Abstract][Full Text] [Related]
35. Retrospective study of endoscopic treatment in children with primary vesicoureteral reflux and multivariate analysis of factors for failure.
Akin Y; Gulmez H; Güntekin E; Baykara M; Yucel S
Scand J Urol; 2014 Dec; 48(6):565-70. PubMed ID: 25028806
[TBL] [Abstract][Full Text] [Related]
36. Endoscopic Injection of Dextranomer/Hyaluronic Acid as First Line Treatment in 851 Consecutive Children with High Grade Vesicoureteral Reflux: Efficacy and Long-Term Results.
Friedmacher F; Colhoun E; Puri P
J Urol; 2018 Sep; 200(3):650-655. PubMed ID: 29551405
[TBL] [Abstract][Full Text] [Related]
37. Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings.
Stenberg A; Larsson E; Läckgren G
J Urol; 2003 Mar; 169(3):1109-13. PubMed ID: 12576864
[TBL] [Abstract][Full Text] [Related]
38. Learning from the learning curve: factors associated with successful endoscopic correction of vesicoureteral reflux using dextranomer/hyaluronic acid copolymer.
Dave S; Lorenzo AJ; Khoury AE; Braga LH; Skeldon SJ; Suoub M; Farhat W; Pippi Salle JL; Bägli DJ
J Urol; 2008 Oct; 180(4 Suppl):1594-9; discussion 1599-600. PubMed ID: 18710756
[TBL] [Abstract][Full Text] [Related]
39. Subureteral injection of dextranomer/hyaluronic acid copolymer for persistent vesicoureteral reflux following ureteroneocystostomy.
Jung C; DeMarco RT; Lowrance WT; Pope JC; Adams MC; Dietrich MS; Brock JW
J Urol; 2007 Jan; 177(1):312-5. PubMed ID: 17162075
[TBL] [Abstract][Full Text] [Related]
40. Long-term results of endoscopic treatment of vesicoureteral reflux in children: comparison of different bulking agents.
Stredele RJ; Dietz HG; Stehr M
J Pediatr Urol; 2013 Feb; 9(1):71-6. PubMed ID: 22212178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
